Study reveals Real-World treatment persistence in lung fibrosis patients
NCT ID NCT06485635
First seen Nov 01, 2025 · Last updated May 09, 2026 · Updated 27 times
Summary
This completed study looked at over 10,000 people in France with idiopathic pulmonary fibrosis to see how long they stayed on antifibrotic medication. The goal was to measure the percentage still taking the drug after 30 months and find reasons why some stop early. No direct treatment was given; instead, researchers analyzed existing health records to understand real-world medication use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IDIOPATHIC PULMONARY FIBROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinityx
Boulogne-Billancourt, 92100, France
Conditions
Explore the condition pages connected to this study.